Published in J Clin Microbiol on November 01, 1984
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol (1997) 1.84
Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis. J Clin Microbiol (1989) 1.64
Major outbreak of pertussis in northern Alberta, Canada: analysis of discrepant direct fluorescent-antibody and culture results by using polymerase chain reaction methodology. J Clin Microbiol (1993) 1.39
Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol (2002) 1.37
Comparison of throat and nasopharyngeal swab specimens for culture diagnosis of Bordetella pertussis infection. J Clin Microbiol (1987) 1.33
Pertussis: the disease and new diagnostic methods. Clin Microbiol Rev (1988) 1.16
Comparison of three kinds of blood and two incubation atmospheres for cultivation of Bordetella pertussis on charcoal agar. J Clin Microbiol (1989) 1.10
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis. J Clin Microbiol (1990) 0.99
Evaluation and validation of a monoclonal immunofluorescent reagent for direct detection of Bordetella pertussis. J Clin Microbiol (1995) 0.88
Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material. J Clin Microbiol (1988) 0.87
Unexpected isolation of Bordetella pertussis from a blood culture. J Clin Microbiol (1994) 0.81
Failure of charcoal-horse-blood broth with cephalexin to significantly increase rate of Bordetella isolation from clinical specimens. J Clin Microbiol (1988) 0.81
Limited applicability of direct fluorescent-antibody testing for Bordetella sp. and Legionella sp. specimens for the clinical microbiology laboratory. J Clin Microbiol (2007) 0.77
Vaccination against whooping-cough. Efficacy versus risks. Lancet (1977) 5.25
Enrichment medium for the isolation of Bordetella. J Clin Microbiol (1977) 3.98
Development of a pertussis component vaccine in Japan. Lancet (1984) 3.94
Antimicrobial treatment of pertussis. J Pediatr (1969) 3.77
Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62
Japan's experience in pertussis epidemiology and vaccination in the past thirty years. Jpn J Med Sci Biol (1980) 1.32
Pertussis disease, vaccine, and controversy. JAMA (1984) 1.30
Pertussis in the United States, 1979: a look at vaccine efficacy. J Infect Dis (1981) 1.21
Pertussis outbreak, Maryland 1982. Md State Med J (1983) 0.89
Pertussis vaccine. Pediatr Infect Dis (1983) 0.88
A tale of tularemia. Pediatr Infect Dis (1984) 0.87
Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med (1987) 7.82
Phylogenetic species recognition and species concepts in fungi. Fungal Genet Biol (2000) 7.71
Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol (1988) 5.71
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol (1987) 2.59
Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis (1995) 2.31
Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest (1992) 2.25
Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1993) 2.22
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Biotype of Haemophilus influenzae: correlation with virulence and ampicillin resistance. J Infect Dis (1983) 1.78
The Calyptogena magnifica chemoautotrophic symbiont genome. Science (2007) 1.73
Relative frequency of Clostridium difficile in patients with diarrheal disease. J Clin Microbiol (1981) 1.56
Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis (1991) 1.55
Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis (1990) 1.54
Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med (2001) 1.52
Survival of human immunodeficiency virus in blood culture systems. Arch Pathol Lab Med (1988) 1.51
Cerebrospinal fluid analysis in systemically ill children without central nervous system disease. Pediatrics (1995) 1.51
Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol (1996) 1.49
In vitro susceptibility testing of topical antimicrobial agents used in pediatric burn patients: comparison of two methods. J Burn Care Rehabil (1997) 1.45
Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis (1988) 1.42
Using itraconazole to clear Batrachochytrium dendrobatidis infection, and subsequent depigmentation of Alytes muletensis tadpoles. Dis Aquat Organ (2009) 1.38
Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J (1994) 1.34
Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients. J Pediatr (1986) 1.33
Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases. J Clin Microbiol (1993) 1.28
Clinical, laboratory, and environmental features of infant botulism in Southeastern Pennsylvania. Pediatrics (1985) 1.24
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Eur J Clin Microbiol (1987) 1.21
Capnocytophaga ochracea septicemia. J Clin Microbiol (1981) 1.18
Nutritional requirements for synthesis of heat-labile enterotoxin by enterotoxigenic strains of Escherichia coli. Infect Immun (1979) 1.18
Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol (1995) 1.16
Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds. J Pediatr (1985) 1.16
Speciation despite globally overlapping distributions in Penicillium chrysogenum: the population genetics of Alexander Fleming's lucky fungus. Mol Ecol (2011) 1.15
Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol (1995) 1.14
Pyogenic arthritis in infants and children: a review of 95 cases. Pediatr Infect Dis (1987) 1.13
Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant (2000) 1.12
Evaluation of the campyslide agglutination test for confirmatory identification of selected Campylobacter species. J Clin Microbiol (1988) 1.09
Absorption of oral vancomycin - possible associated toxicity. Int J Pediatr Nephrol (1983) 1.08
Predictors of infectious complications after burn injuries in children. Pediatr Infect Dis J (2000) 1.06
The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med (1997) 1.04
Emergence of isolates resistant to ampicillin. Am J Dis Child (1989) 1.03
Clostridium difficile in patients with cystic fibrosis. Am J Dis Child (1985) 1.03
Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA (1981) 1.02
Clostridium difficile peritonitis in a neonate. A case report. Arch Pathol Lab Med (1984) 1.01
Emergence of amphibian chytridiomycosis in Britain. Vet Rec (2005) 1.01
Pertussis is rare in human immunodeficiency virus disease. Am Rev Respir Dis (1993) 1.00
Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid. J Clin Microbiol (1994) 0.97
In vivo selection for transmissible drug resistance in Salmonella typhi during antimicrobial therapy. Antimicrob Agents Chemother (1990) 0.95
Clostridium difficile cytotoxin in a pediatric population. Am J Dis Child (1983) 0.93
Two case reports and review of vascular catheter-associated bacteremia caused by nontuberculous Mycobacterium species. Pediatr Infect Dis J (1996) 0.92
Bacteremia due to Bacteroides fragilis after elective appendectomy in renal transplant recipients. J Infect Dis (1981) 0.92
Non-invasive sampling methods for the detection of Batrachochytrium dendrobatidis in archived amphibians. Dis Aquat Organ (2009) 0.92
Quality assurance study of bacterial antigen testing of cerebrospinal fluid. J Clin Microbiol (1995) 0.90
Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin. Infect Immun (1983) 0.90
Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr Pulmonol (1997) 0.89
Evaluation of the latex agglutination test for detection of Clostridium difficile. Arch Pathol Lab Med (1992) 0.89
Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by neuropeptides. J Immunol (1988) 0.88
The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk. Clin Exp Rheumatol (2009) 0.88
Nosocomial infections in the neonatal intensive care unit. Curr Opin Infect Dis (2001) 0.88
Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells. Am Rev Respir Dis (1993) 0.86
Possible association of intussusception with rotavirus vaccination. American Academy of Pediatrics. Committee on Infectious Diseases. Pediatrics (1999) 0.86
Taxonomic and diagnostic markers for identification of Coccidioides immitis and Coccidioides posadasii. Med Mycol (2007) 0.86
Post-varicella streptococcal pyomyositis. Pediatr Infect Dis J (1989) 0.82
Antigenuria after Haemophilus influenzae type b polysaccharide vaccination. J Pediatr (1986) 0.81
Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study. J Pediatr (1986) 0.81
Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol (1994) 0.80
Diarrheal disease in the hospitalized patient. Infect Control (1986) 0.79
Levamisole effects on major histocompatibility complex and adhesion molecule expression and on myeloid cell adhesion to human colon tumor cell lines. J Natl Cancer Inst (1996) 0.79
Levamisole causes differential cytokine expression by elicited mouse peritoneal macrophages. J Leukoc Biol (1992) 0.79
Study of antibiotic prophylaxis during burn wound debridement in children. J Burn Care Rehabil (1997) 0.78
Potentiation of Balb/3T3 fibroblast proliferative response by interleukin-1 and epidermal growth factor. Cell Immunol (1988) 0.77
In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center. Antimicrob Agents Chemother (1991) 0.77
Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by substance P. Ann N Y Acad Sci (1988) 0.77
Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic. Eur J Clin Microbiol (1987) 0.77
Metabolism during delayed hatching in terrestrial eggs of a marine fish, the grunion Leuresthes tenuis. Physiol Zool (1998) 0.77
Effect of imipenem-cilastatin therapy on fecal flora. Antimicrob Agents Chemother (1986) 0.77
Epidemic of meningitis and febrile illness in neonates caused by ECHO type 11 virus in Philadelphia. Pediatr Infect Dis (1983) 0.76
In vivo and in vitro studies of Clostridium difficile-induced disease in hamsters fed an atherogenic, high-fat diet. Lab Anim Sci (1995) 0.76
Inferring infection processes of a parasitic nematode using population genetics. Parasitology (2000) 0.76
Differentiation of Clostridium difficile toxin from Clostridium botulinum toxin by the mouse lethality test. Appl Environ Microbiol (1983) 0.75
Prevention of hepatitis B in adolescents. Pediatrics (2001) 0.75
Effect of rifampin on Staphylococcus aureus colonization in children on chronic peritoneal dialysis. Pediatr Nephrol (1995) 0.75
Ventricular fluid pleocytosis in children with ventriculoperitoneal shunts. Pediatr Infect Dis J (1996) 0.75
Transfusion-associated acquired immunodeficiency syndrome--what is the risk? Pediatrics (1987) 0.75
Limp as a presenting sign of meningitis. Pediatr Infect Dis J (1990) 0.75
Polymicrobial soft tissue abscesses in patients with cyanotic congenital heart disease. Pediatr Infect Dis J (1996) 0.75
Prolonged bacteremia with catheter-related central venous thrombosis. Am J Dis Child (1990) 0.75
Nosocomial pulmonary infections in children. J Thorac Imaging (1986) 0.75
Absence of significant effects by levamisole on circulating neutrophil levels in normal mice treated with 5-FU. Immunopharmacology (1994) 0.75
The 1999-2000 ACC task analysis of nurse-midwifery/midwifery practice: a consideration of the concept of professional issues. J Midwifery Womens Health (2001) 0.75
Yersinia enterocolitica meningitis and osteomyelitis: a case report. Diagn Microbiol Infect Dis (1987) 0.75
Effect of tolmetin glycine amide (McN-4366), a prodrug of tolmetin sodium, on adjuvant arthritis in the rat. J Pharmacol Exp Ther (1988) 0.75
Cerebral calcifications in a neonate with candidiasis. Pediatr Infect Dis J (1990) 0.75
Idiopathic pulmonary fibrosis. Another cause of ventilation/perfusion mismatch. Clin Nucl Med (1986) 0.75
Effect of lindane on nitroreductase and dechlorinase enzyme activity in the gastrointestinal tract. Toxicol Lett (1990) 0.75
Nutrition evaluation of published weight-reducing diets. J Am Diet Assoc (1985) 0.75
Impact of treatment guidelines on use of ribavirin. Am J Dis Child (1990) 0.75